The global Coronavirus Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Coronavirus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Diagnostics.

Report Scope

The Coronavirus Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronavirus Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Coronavirus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Coronavirus Diagnostics Market Report

Report Metric	Details
Report Name	Coronavirus Diagnostics Market
CAGR	5%
Segment by Type	Laboratory Instrument Testing Kit Test
Segment by Application	Hospital Public Health Laboratory Internal Medicine Laboratory Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Abbott, Bio-Rad Laboratories, Beckman Coulter, Becton,Dickinson and Company, Lonza, bioMerieux, Hologic, Qiagen, GSK Biologicals, PerkinElmer, Ortho-Clinical Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Coronavirus Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Coronavirus Diagnostics Market report?

Ans: The main players in the Coronavirus Diagnostics Market are Roche Diagnostics, Abbott, Bio-Rad Laboratories, Beckman Coulter, Becton,Dickinson and Company, Lonza, bioMerieux, Hologic, Qiagen, GSK Biologicals, PerkinElmer, Ortho-Clinical Diagnostics

What are the Application segmentation covered in the Coronavirus Diagnostics Market report?

Ans: The Applications covered in the Coronavirus Diagnostics Market report are Hospital, Public Health Laboratory, Internal Medicine Laboratory, Other

What are the Type segmentation covered in the Coronavirus Diagnostics Market report?

Ans: The Types covered in the Coronavirus Diagnostics Market report are Laboratory Instrument Testing, Kit Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Coronavirus Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Laboratory Instrument Testing

1.2.3 Kit Test

1.3 Market by Application

1.3.1 Global Coronavirus Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Public Health Laboratory

1.3.4 Internal Medicine Laboratory

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Coronavirus Diagnostics Market Perspective (2019-2030)

2.2 Coronavirus Diagnostics Growth Trends by Region

2.2.1 Global Coronavirus Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Coronavirus Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Coronavirus Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Coronavirus Diagnostics Market Dynamics

2.3.1 Coronavirus Diagnostics Industry Trends

2.3.2 Coronavirus Diagnostics Market Drivers

2.3.3 Coronavirus Diagnostics Market Challenges

2.3.4 Coronavirus Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Coronavirus Diagnostics Players by Revenue

3.1.1 Global Top Coronavirus Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Coronavirus Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Coronavirus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Coronavirus Diagnostics Revenue

3.4 Global Coronavirus Diagnostics Market Concentration Ratio

3.4.1 Global Coronavirus Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Diagnostics Revenue in 2023

3.5 Coronavirus Diagnostics Key Players Head office and Area Served

3.6 Key Players Coronavirus Diagnostics Product Solution and Service

3.7 Date of Enter into Coronavirus Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Coronavirus Diagnostics Breakdown Data by Type

4.1 Global Coronavirus Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Coronavirus Diagnostics Forecasted Market Size by Type (2025-2030)

5 Coronavirus Diagnostics Breakdown Data by Application

5.1 Global Coronavirus Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Coronavirus Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Coronavirus Diagnostics Market Size (2019-2030)

6.2 North America Coronavirus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Coronavirus Diagnostics Market Size by Country (2019-2024)

6.4 North America Coronavirus Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Coronavirus Diagnostics Market Size (2019-2030)

7.2 Europe Coronavirus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Coronavirus Diagnostics Market Size by Country (2019-2024)

7.4 Europe Coronavirus Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Coronavirus Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Coronavirus Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Coronavirus Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Coronavirus Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Coronavirus Diagnostics Market Size (2019-2030)

9.2 Latin America Coronavirus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Coronavirus Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Coronavirus Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Coronavirus Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Coronavirus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Coronavirus Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Coronavirus Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Detail

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Coronavirus Diagnostics Introduction

11.1.4 Roche Diagnostics Revenue in Coronavirus Diagnostics Business (2019-2024)

11.1.5 Roche Diagnostics Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Coronavirus Diagnostics Introduction

11.2.4 Abbott Revenue in Coronavirus Diagnostics Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Detail

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Coronavirus Diagnostics Introduction

11.3.4 Bio-Rad Laboratories Revenue in Coronavirus Diagnostics Business (2019-2024)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Beckman Coulter

11.4.1 Beckman Coulter Company Detail

11.4.2 Beckman Coulter Business Overview

11.4.3 Beckman Coulter Coronavirus Diagnostics Introduction

11.4.4 Beckman Coulter Revenue in Coronavirus Diagnostics Business (2019-2024)

11.4.5 Beckman Coulter Recent Development

11.5 Becton,Dickinson and Company

11.5.1 Becton,Dickinson and Company Company Detail

11.5.2 Becton,Dickinson and Company Business Overview

11.5.3 Becton,Dickinson and Company Coronavirus Diagnostics Introduction

11.5.4 Becton,Dickinson and Company Revenue in Coronavirus Diagnostics Business (2019-2024)

11.5.5 Becton,Dickinson and Company Recent Development

11.6 Lonza

11.6.1 Lonza Company Detail

11.6.2 Lonza Business Overview

11.6.3 Lonza Coronavirus Diagnostics Introduction

11.6.4 Lonza Revenue in Coronavirus Diagnostics Business (2019-2024)

11.6.5 Lonza Recent Development

11.7 bioMerieux

11.7.1 bioMerieux Company Detail

11.7.2 bioMerieux Business Overview

11.7.3 bioMerieux Coronavirus Diagnostics Introduction

11.7.4 bioMerieux Revenue in Coronavirus Diagnostics Business (2019-2024)

11.7.5 bioMerieux Recent Development

11.8 Hologic

11.8.1 Hologic Company Detail

11.8.2 Hologic Business Overview

11.8.3 Hologic Coronavirus Diagnostics Introduction

11.8.4 Hologic Revenue in Coronavirus Diagnostics Business (2019-2024)

11.8.5 Hologic Recent Development

11.9 Qiagen

11.9.1 Qiagen Company Detail

11.9.2 Qiagen Business Overview

11.9.3 Qiagen Coronavirus Diagnostics Introduction

11.9.4 Qiagen Revenue in Coronavirus Diagnostics Business (2019-2024)

11.9.5 Qiagen Recent Development

11.10 GSK Biologicals

11.10.1 GSK Biologicals Company Detail

11.10.2 GSK Biologicals Business Overview

11.10.3 GSK Biologicals Coronavirus Diagnostics Introduction

11.10.4 GSK Biologicals Revenue in Coronavirus Diagnostics Business (2019-2024)

11.10.5 GSK Biologicals Recent Development

11.11 PerkinElmer

11.11.1 PerkinElmer Company Detail

11.11.2 PerkinElmer Business Overview

11.11.3 PerkinElmer Coronavirus Diagnostics Introduction

11.11.4 PerkinElmer Revenue in Coronavirus Diagnostics Business (2019-2024)

11.11.5 PerkinElmer Recent Development

11.12 Ortho-Clinical Diagnostics

11.12.1 Ortho-Clinical Diagnostics Company Detail

11.12.2 Ortho-Clinical Diagnostics Business Overview

11.12.3 Ortho-Clinical Diagnostics Coronavirus Diagnostics Introduction

11.12.4 Ortho-Clinical Diagnostics Revenue in Coronavirus Diagnostics Business (2019-2024)

11.12.5 Ortho-Clinical Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Becton Dickinson and Company

Ortho Clinical Diagnostics

Qiagen

List of Tables

Table 1. Global Coronavirus Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Laboratory Instrument Testing

Table 3. Key Players of Kit Test

Table 4. Global Coronavirus Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Coronavirus Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Coronavirus Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Coronavirus Diagnostics Market Share by Region (2019-2024)

Table 8. Global Coronavirus Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Coronavirus Diagnostics Market Share by Region (2025-2030)

Table 10. Coronavirus Diagnostics Market Trends

Table 11. Coronavirus Diagnostics Market Drivers

Table 12. Coronavirus Diagnostics Market Challenges

Table 13. Coronavirus Diagnostics Market Restraints

Table 14. Global Coronavirus Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Coronavirus Diagnostics Market Share by Players (2019-2024)

Table 16. Global Top Coronavirus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Diagnostics as of 2023)

Table 17. Ranking of Global Top Coronavirus Diagnostics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Coronavirus Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Coronavirus Diagnostics Product Solution and Service

Table 21. Date of Enter into Coronavirus Diagnostics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Coronavirus Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Coronavirus Diagnostics Revenue Market Share by Type (2019-2024)

Table 25. Global Coronavirus Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Coronavirus Diagnostics Revenue Market Share by Type (2025-2030)

Table 27. Global Coronavirus Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Coronavirus Diagnostics Revenue Market Share by Application (2019-2024)

Table 29. Global Coronavirus Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Coronavirus Diagnostics Revenue Market Share by Application (2025-2030)

Table 31. North America Coronavirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Coronavirus Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Coronavirus Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Coronavirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Coronavirus Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Coronavirus Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Coronavirus Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Coronavirus Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Coronavirus Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Coronavirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Coronavirus Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Coronavirus Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Coronavirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Coronavirus Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Coronavirus Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Roche Diagnostics Company Detail

Table 47. Roche Diagnostics Business Overview

Table 48. Roche Diagnostics Coronavirus Diagnostics Product

Table 49. Roche Diagnostics Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 50. Roche Diagnostics Recent Development

Table 51. Abbott Company Detail

Table 52. Abbott Business Overview

Table 53. Abbott Coronavirus Diagnostics Product

Table 54. Abbott Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 55. Abbott Recent Development

Table 56. Bio-Rad Laboratories Company Detail

Table 57. Bio-Rad Laboratories Business Overview

Table 58. Bio-Rad Laboratories Coronavirus Diagnostics Product

Table 59. Bio-Rad Laboratories Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 60. Bio-Rad Laboratories Recent Development

Table 61. Beckman Coulter Company Detail

Table 62. Beckman Coulter Business Overview

Table 63. Beckman Coulter Coronavirus Diagnostics Product

Table 64. Beckman Coulter Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 65. Beckman Coulter Recent Development

Table 66. Becton,Dickinson and Company Company Detail

Table 67. Becton,Dickinson and Company Business Overview

Table 68. Becton,Dickinson and Company Coronavirus Diagnostics Product

Table 69. Becton,Dickinson and Company Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 70. Becton,Dickinson and Company Recent Development

Table 71. Lonza Company Detail

Table 72. Lonza Business Overview

Table 73. Lonza Coronavirus Diagnostics Product

Table 74. Lonza Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 75. Lonza Recent Development

Table 76. bioMerieux Company Detail

Table 77. bioMerieux Business Overview

Table 78. bioMerieux Coronavirus Diagnostics Product

Table 79. bioMerieux Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 80. bioMerieux Recent Development

Table 81. Hologic Company Detail

Table 82. Hologic Business Overview

Table 83. Hologic Coronavirus Diagnostics Product

Table 84. Hologic Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 85. Hologic Recent Development

Table 86. Qiagen Company Detail

Table 87. Qiagen Business Overview

Table 88. Qiagen Coronavirus Diagnostics Product

Table 89. Qiagen Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 90. Qiagen Recent Development

Table 91. GSK Biologicals Company Detail

Table 92. GSK Biologicals Business Overview

Table 93. GSK Biologicals Coronavirus Diagnostics Product

Table 94. GSK Biologicals Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 95. GSK Biologicals Recent Development

Table 96. PerkinElmer Company Detail

Table 97. PerkinElmer Business Overview

Table 98. PerkinElmer Coronavirus Diagnostics Product

Table 99. PerkinElmer Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 100. PerkinElmer Recent Development

Table 101. Ortho-Clinical Diagnostics Company Detail

Table 102. Ortho-Clinical Diagnostics Business Overview

Table 103. Ortho-Clinical Diagnostics Coronavirus Diagnostics Product

Table 104. Ortho-Clinical Diagnostics Revenue in Coronavirus Diagnostics Business (2019-2024) & (US$ Million)

Table 105. Ortho-Clinical Diagnostics Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Coronavirus Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Coronavirus Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Laboratory Instrument Testing Features

Figure 4. Kit Test Features

Figure 5. Global Coronavirus Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Coronavirus Diagnostics Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Public Health Laboratory Case Studies

Figure 9. Internal Medicine Laboratory Case Studies

Figure 10. Other Case Studies

Figure 11. Coronavirus Diagnostics Report Years Considered

Figure 12. Global Coronavirus Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Coronavirus Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Coronavirus Diagnostics Market Share by Region: 2023 VS 2030

Figure 15. Global Coronavirus Diagnostics Market Share by Players in 2023

Figure 16. Global Top Coronavirus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Diagnostics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Coronavirus Diagnostics Revenue in 2023

Figure 18. North America Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Coronavirus Diagnostics Market Share by Country (2019-2030)

Figure 20. United States Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Coronavirus Diagnostics Market Share by Country (2019-2030)

Figure 24. Germany Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Coronavirus Diagnostics Market Share by Region (2019-2030)

Figure 32. China Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Coronavirus Diagnostics Market Share by Country (2019-2030)

Figure 40. Mexico Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Coronavirus Diagnostics Market Share by Country (2019-2030)

Figure 44. Turkey Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Coronavirus Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Roche Diagnostics Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 47. Abbott Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 48. Bio-Rad Laboratories Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 49. Beckman Coulter Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 50. Becton,Dickinson and Company Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 51. Lonza Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 52. bioMerieux Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 53. Hologic Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 54. Qiagen Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 55. GSK Biologicals Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 56. PerkinElmer Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 57. Ortho-Clinical Diagnostics Revenue Growth Rate in Coronavirus Diagnostics Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions